Inversion recovery single-shot turboFLASH for assessment of myocardial infarction at 3 Tesla

Investigative Radiology

Volumn 42, Issue 6, 2007, Pages 361-371

  Bauner, Kerstin U ^a   Muehling, Olaf ^a   Wintersperger, Bernd J ^a   Winnik, Eva ^b   Reiser, Maximilian F ^a   Huber, Armin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b SIEMENS AG   (Germany)

Author keywords

3.0 Tesla; Infarction; IR turboFLASH; MRI; Myocardium; Viability

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEART INFARCTION; HEART MUSCLE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 34249018851     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000262565.89298.59     Document Type: Article

References (32)

1. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997;96:793-800.
2. Schwaiger M, Pirich C. [Positron emission tomography]. Z Kardiol. 2000;89(Suppl 1):59-66.
3. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
4. Kuhl HP, Papavasiliu TS, Beek AM, et al. Myocardial viability: rapid assessment with delayed contrast-enhanced MR imaging with threedimensional inversion-recovery prepared pulse sequence. Radiology. 2004;230:576-582.
5. Rehwald WG, Fieno DS, Chen EL, et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation. 2002;105:224-229.
6. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-379.
7. Fieno DS, Hillenbrand HB, Rehwald WG, et al. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol. 2004;43:2124-2131.
8. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
9. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215-223.
10. Huber A, Schonberg SO, Spannagl B, et al. Determining myocardial viability in myocardial infarct. Comparison of single and multisclice MRI techniques with TurboFlash and TrueFISP sequences [in German]. Radiologe. 2004;44:146-151.
11. Huber AM, Schoenberg SO, Hayes C, et al. Phase-sensitive inversionrecovery MR imaging in the detection of myocardial infarction. Radiology. 2005;237:854-860.
12. Li W, Li BS, Polzin JA, et al. Myocardial delayed enhancement imaging using inversion recovery single-shot steady-state free precession: Initial experience. J Magn Reson Imaging. 2004;20:327-330.
13. Huber A, Bauner K, Wintersperger BJ, et al. Phase-sensitive inversion recovery (PSIR) single-shot TrueFISP for assessment of myocardial infarction at 3 Tesla. Invest Radiol. 2006;41:148-153.
14. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108:1945-1953.
15. Kellman P, Arai AE, McVeigh ER, et al. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002;47:372-383.
16. Kellman P, Larson AC, Hsu LY, et al. Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med. 2005;53:194-200.
17. Jimenez Borreguero LJ, Ruiz-Salmeron R. Assessment of myocardial viability in patients before revascularization [in Spanish]. Rev Esp Cardiol. 2003;56:721-733.
18. Gupta A, Lee VS, Chung YC, et al. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology. 2004;233:921-926.
19. Chung YC, Lee VS, Laub G, et al. Inversion Recovery Cine TrueFISP. ISMRM Scientific Meeting. 2002;219.
20. Spuentrup E, Buecker A, Karassimos E, et al. Navigator-gated and real-time motion corrected free-breathing MR Imaging of myocardial late enhancement. Rofo. 2002;174:562-567.
21. Hendel RC, Kramer CM, Patel MP, et al. Appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. J Am Coll Cardiol. 2006;48:1475-1497.
22. Fieno DS, Kim RJ, Chen EL, et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol. 2000;36:1985-1991.
23. Hunold P, Brandt-Mainz K, Freudenberg L, et al. Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging - comparison of the late enhancement technique with positron emission tomography [in German]. Rofo. 2002;174:867-873.
24. van Dijkman PR, Hold KM, van der Laarse A, et al. Sequential analysis of infarcted and normal myocardium in piglets using in vivo gadoliniumenhanced MR images. Magn Reson Imaging. 1993;11:207-218.
25. Depre C, Vanoverschelde JL, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol. 1995;268:H1265-H1275.
26. Wesbey G, Higgins CB, Lanzer P, et al. Imaging and characterization of acute myocardial infarction in vivo by gated nuclear magnetic resonance. Circulation. 1984;69:125-130.
27. Johnston DL, Brady TJ, Ratner AV, et al. Assessment of myocardial ischemia with proton magnetic resonance: effects of a three hour coronary occlusion with and without reperfusion. Circulation. 1985;71:595-601.
28. Ratner AV, Okada RD, Newell JB, et al. The relationship between proton nuclear magnetic resonance relaxation parameters and myocardial perfusion with acute coronary arterial occlusion and reperfusion. Circulation. 1985;71:823-828.
29. Higgins CB, Hricak H, Gamsu G, et al. Clinical nuclear magnetic resonance imaging of the body. Semin Nucl Med. 1983;13:347-363.
30. Gutberlet M, Noeske R, Schwinge K, et al. Comprehensive cardiac magnetic resonance imaging at 3.0 Tesla: feasibility and implications for clinical applications. Invest Radiol. 2006;41:154-167.
31. Klumpp B, Fenchel M, Hoevelborn T, et al. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla. Invest Radiol. 2006;41:661-667.
32. Greenman RL, Shirosky JE, Mulkern RV, et al. Double inversion black-blood fast spin-echo imaging of the human heart: a comparison between 1.5 T and 3.0 T. J Magn Reson Imaging. 2003;17:648-655.